Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

We need safe, affordable drugs to fight coronaviruses effectively.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Iron therapy resolved uncooked rice cravings and symptoms in women with iron deficiency.

Diabetes may lower the risk of prostate cancer.

COVID-19 affects many body systems, causing a wide range of symptoms and complications.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Iron balance is crucial for skin health, affecting conditions like psoriasis and hair loss.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

iPSCs are promising for studying and treating COVID-19.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

HAT-L4 is crucial for preventing body fluid loss by maintaining skin barrier integrity.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Iron deficiency might be linked to hair loss, but more research is needed.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.